Showing 20 of 203 recruiting trials for “combined-hepatocellular-carcinoma-and-cholangiocarcinoma”
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
The Dragon PLC Trial (DRAGON-PLC)
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
👨⚕️ Kangshun Zhu, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
👨⚕️ Héloise BOURIEN, Dr, Centre de lutte contre le cancer Eugène Marquis📍 6 sites📅 Started Mar 2025View details ↗
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
A Study of MGC028 in Participants With Advanced Solid Tumors
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
RecruitingNCT06746194 ↗
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
Enrolling by InvitationNCT06624189 ↗
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery
RecruitingNCT06813508 ↗
Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
👨⚕️ Fabio Piscaglia, Prof, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Nov 2024View details ↗
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
Mts105 for Advanced Hepatocellular Carcinoma
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →